Studying Kidney Scarring with FAPI PET/CT
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study uses a special PET/CT scan to look for scarring in the kidneys. The goal is to see if the scan can detect kidney fibrosis better than current methods.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had a biopsy of your own kidney to look for scarring or disease.
- You are 18 years old or older.
- You are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses advanced imaging (PET/MRI) to look at how kidney disease affects the heart and blood vessels. It may help doctors better understand and treat chronic kidney disease.
This trial uses a special PET/CT scan to look at kidney scarring (fibrosis) in people with chronic kidney disease. It could help doctors monitor kidney damage without needing a biopsy.
This study tests a new imaging scan (called 18F-FAPI PET/CT) that may help detect scarring in the lungs, heart, or blood vessels. If you have a heart, lung, or blood vessel condition that could cause scarring, this scan might show damage earlier and help doctors plan better treatment.
This study uses a special PET scan to look for scarring (fibrosis) in the heart muscle of people with heart failure. It may help doctors better understand why some hearts get stiff or weak.
This early (Phase 1) study compares two types of PET-CT scans to see how well they detect and measure lung scarring (pulmonary fibrosis). It may help doctors choose the best scan test for diagnosis in the future.
This study tests a new type of PET/CT scan (FAPI-74) to see if it can detect areas of scarring (fibrosis) in the body. It may help doctors better understand and monitor conditions like certain cancers, infections after transplants, and heart inflammation.
Hear when a new Chronic kidney disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.